This surgery is ideal for patients who may be deemed inoperable or at high risk for open heart surgery. For patients like Ms.
Southern Research Institute, developer of seven FDA-approved cancer drugs, and the University of Alabama at Birmingham, a leading research institution ranked 23rd nationally in NIH funding, have ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Two awards are for $1.2 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results